BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 31271515)

  • 1. Discoidin domain receptors: A promising target in melanoma.
    Reger de Moura C; Battistella M; Sohail A; Caudron A; Feugeas JP; Podgorniak MP; Pages C; Mazouz Dorval S; Marco O; Menashi S; Fridman R; Lebbé C; Mourah S; Jouenne F
    Pigment Cell Melanoma Res; 2019 Sep; 32(5):697-707. PubMed ID: 31271515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of kindlin-3 increases human melanoma aggressiveness through the collagen-activated tyrosine kinase receptor DDR1.
    Reger De Moura C; Louveau B; Jouenne F; Vilquin P; Battistella M; Bellahsen-Harrar Y; Sadoux A; Menashi S; Dumaz N; Lebbé C; Mourah S
    Oncogene; 2024 May; 43(21):1620-1630. PubMed ID: 38570692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma.
    Hur H; Ham IH; Lee D; Jin H; Aguilera KY; Oh HJ; Han SU; Kwon JE; Kim YB; Ding K; Brekken RA
    BMC Cancer; 2017 Jan; 17(1):87. PubMed ID: 28143619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of DDR1 reduces invasive features of human A375 melanoma, HT29 colon carcinoma and SK-HEP hepatoma cells.
    Romayor I; Badiola I; Olaso E
    Cell Adh Migr; 2020 Dec; 14(1):69-81. PubMed ID: 32090682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discoidin domain receptor 1 promotes hepatocellular carcinoma progression through modulation of SLC1A5 and the mTORC1 signaling pathway.
    Pan Y; Han M; Zhang X; He Y; Yuan C; Xiong Y; Li X; Zeng C; Lu K; Zhu H; Lu X; Liu Q; Liang H; Liao Z; Ding Z; Zhang Z; Chen X; Zhang W; Zhang B
    Cell Oncol (Dordr); 2022 Feb; 45(1):163-178. PubMed ID: 35089546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of DDR1 with antibody-drug conjugates has antitumor effects in a mouse model of colon carcinoma.
    Tao Y; Wang R; Lai Q; Wu M; Wang Y; Jiang X; Zeng L; Zhou S; Li Z; Yang T; Yao Y; Wu Y; Yu L; Fu Y; Lai W; Peng Y; Lu Y; Zhang Z; Guo C; Zhang G; Gou L; Yang J
    Mol Oncol; 2019 Sep; 13(9):1855-1873. PubMed ID: 31116512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-Regulation of DDR1 Induces Apoptosis and Inhibits EMT through Phosphorylation of Pyk2/MKK7 in DU-145 and Lncap-FGC Prostate Cancer Cell Lines.
    Azizi R; Fallahian F; Aghaei M; Salemi Z
    Anticancer Agents Med Chem; 2020; 20(8):1009-1016. PubMed ID: 32275493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of collagen receptor discoidin domain receptor-1 (DDR1) reduces cell survival, homing, and colonization in lung cancer bone metastasis.
    Valencia K; Ormazábal C; Zandueta C; Luis-Ravelo D; Antón I; Pajares MJ; Agorreta J; Montuenga LM; Martínez-Canarias S; Leitinger B; Lecanda F
    Clin Cancer Res; 2012 Feb; 18(4):969-80. PubMed ID: 22223527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells.
    Song J; Chen X; Bai J; Liu Q; Li H; Xie J; Jing H; Zheng J
    Tumour Biol; 2016 Aug; 37(8):11509-21. PubMed ID: 27020590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice.
    Sun X; Gupta K; Wu B; Zhang D; Yuan B; Zhang X; Chiang HC; Zhang C; Curiel TJ; Bendeck MP; Hursting S; Hu Y; Li R
    J Biol Chem; 2018 Feb; 293(8):2841-2849. PubMed ID: 29298894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability.
    Badiola I; Villacé P; Basaldua I; Olaso E
    Oncol Rep; 2011 Oct; 26(4):971-8. PubMed ID: 21701781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells.
    Vella V; Malaguarnera R; Nicolosi ML; Palladino C; Spoleti C; Massimino M; Vigneri P; Purrello M; Ragusa M; Morrione A; Belfiore A
    Oncotarget; 2017 Jun; 8(26):43248-43270. PubMed ID: 28591735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of transmembrane receptor tyrosine kinase DDR1-STAT3 cascade by extracellular matrix remodeling promotes liver metastatic colonization in uveal melanoma.
    Dai W; Liu S; Wang S; Zhao L; Yang X; Zhou J; Wang Y; Zhang J; Zhang P; Ding K; Li Y; Pan J
    Signal Transduct Target Ther; 2021 May; 6(1):176. PubMed ID: 33976105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DDR1 and DDR2 physical interaction leads to signaling interconnection but with possible distinct functions.
    Croissant C; Tuariihionoa A; Bacou M; Souleyreau W; Sala M; Henriet E; Bikfalvi A; Saltel F; Auguste P
    Cell Adh Migr; 2018; 12(4):324-334. PubMed ID: 29616590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
    Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
    Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanoma.
    Berestjuk I; Lecacheur M; Carminati A; Diazzi S; Rovera C; Prod'homme V; Ohanna M; Popovic A; Mallavialle A; Larbret F; Pisano S; Audebert S; Passeron T; Gaggioli C; Girard CA; Deckert M; Tartare-Deckert S
    EMBO Mol Med; 2022 Feb; 14(2):e11814. PubMed ID: 34957688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A putative role for Discoidin Domain Receptor 1 in cancer chemoresistance.
    Ambrogio C; Darbo E; Lee SW; Santamaría D
    Cell Adh Migr; 2018; 12(4):394-397. PubMed ID: 29505315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1) Is a Novel Therapeutic Target in Liposarcoma: A Tissue Microarray Study.
    Dean DC; Feng W; Walker RL; Thanindratarn P; Temple HT; Trent JC; Rosenberg AE; Hornicek FJ; Duan Z
    Clin Orthop Relat Res; 2023 Nov; 481(11):2140-2153. PubMed ID: 37768856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live cell measurements of interaction forces and binding kinetics between Discoidin Domain Receptor 1 (DDR1) and collagen I with atomic force microscopy.
    Sarkar A; Sohail A; Dong J; Prunotto M; Shinki K; Fridman R; Hoffmann PM
    Biochim Biophys Acta Gen Subj; 2019 Nov; 1863(11):129402. PubMed ID: 31351093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Discoidin Domain Receptor 1 Reduces Collagen-mediated Tumorigenicity in Pancreatic Ductal Adenocarcinoma.
    Aguilera KY; Huang H; Du W; Hagopian MM; Wang Z; Hinz S; Hwang TH; Wang H; Fleming JB; Castrillon DH; Ren X; Ding K; Brekken RA
    Mol Cancer Ther; 2017 Nov; 16(11):2473-2485. PubMed ID: 28864681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.